Contact: Thonnia Lee, Office of Communications, Public Relations and Marketing
ۿ۴ýUniversity will share $1.1 million from the Breast Cancer Research Foundation of Alabama to support ongoing breast cancer research. In partnership with Auburn University, ۿ۴ýis one of 22 research projects at seven institutions across the state that will share the funding.
ۿ۴ýis partnering with Auburn University on the research to leverage each institution’s strengths, said Dr. Deepa Bedi, who is Tuskegee’s principal investigator and an Associate Professor of Biomedical Sciences. She is collaborating with Auburn University’s Dr. Maninder Sandey.
“We are deeply committed to making a meaningful impact on breast cancer research, with a particular focus on addressing health disparities in underserved communities,” said Dr. Bedi, who holds a patent for her breast cancer research. “My passion lies in empowering our ۿ۴ý to engage in transformative science that not only advances knowledge but also directly improves lives. By involving ۿ۴ý in initiatives like this one, we aim to inspire the next generation of researchers, ensuring they understand the significance of their contributions to addressing a disease that affects millions. My hope is that through their involvement, ۿ۴ý will carry forward the values of innovation, community service, and scientific excellence to create a lasting legacy in the fight against breast cancer.”
The 2024 recipients embody a unique and diverse cohort ready to accomplish huge advancements in breast cancer research, supporting new and innovative solutions and superior patient care.
“Historically and contemporary research at ۿ۴ýhas always sought to improve the human condition,” said Dr. Mark A. Brown, ۿ۴ýUniversity President and CEO. “Breast Cancer research is important anywhere but particularly in the Black Rural South where breast cancer accounts for over 38 percent higher mortality rate. Young Black women have double the mortality rate of young white women. This disproportionally impacts communities of color further increasing the importance of this research grant.”
“This year’s investment of $1,125,000 reinforces our ongoing reputation as a catalyst for important research across Alabama,” said Beth Davis, president and CEO of BCRFA. “Our support allows research to occur that ranges from new early detection strategies to refined innovations in treatment. Ultimately, these investments give increased hope and improved opportunities to Alabamians and others who are fighting breast cancer.”
By leveraging each institution's unique strengths, the partnership fosters interdisciplinary expertise, enhances scientific innovation, and creates a collaborative platform for impactful cancer research, said Dr. Bedi.
“The ultimate goal of this research is to improve therapeutic outcomes for patients with triple-negative breast cancer, a particularly aggressive and difficult-to-treat form of the disease,” she said.
© 2024 ۿ۴ýUniversity